Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD33 (clone D45Y7U). We employs the pUC (EF1α-mKate-c-Jun-XbaI) vector components and the SynExpress system of the miRNA Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD33
Clone
D45Y7U
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
EF1α
Effector Gene
c-Jun
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
miRNA
Carrier Type
pUC
Transformation Accuracy
0.99
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.